Trial Details

RECRUITING
Basic Information
Clinical ID c1468
Identifier NCT05535946
Trial Title ABTECT - Maintenance
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: ABX464|DRUG: Placebo
Participant Information
Sponsor Abivax S.A.
City Birmingham
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2023-01-16
Primary Completion Date 2025-01-26
Completion Date 2025-01-30